About NIMBLE Diagnostics
NIMBLE Diagnostics is a company based in Badalona (Spain) founded in 2022 by O'Callaghan JM Spanish, Oriol Rodriguez Leor, Carolina Galvez-Monton, Susana Amoros Garcia De Valdecasas, and Oriol Iborra Egea.. NIMBLE Diagnostics has raised $1.08 million across 4 funding rounds from investors including Ship2B, European Union and EIC Fund. NIMBLE Diagnostics offers products and services including NIMBLE System. NIMBLE Diagnostics operates in a competitive market with competitors including Imperative Care, LUMA Vision, Verathon, Deltex Medical and eKuore, among others.
- Headquarter Badalona, Spain
- Founders O'Callaghan JM Spanish, Oriol Rodriguez Leor, Carolina Galvez-Monton, Susana Amoros Garcia De Valdecasas, Oriol Iborra Egea
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nimble Diagnostics S.L.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.08 M (USD)
in 4 rounds
-
Latest Funding Round
$2.65 M (USD), Grant
Oct 31, 2023
-
Investors
Ship2B
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NIMBLE Diagnostics
NIMBLE Diagnostics offers a comprehensive portfolio of products and services, including NIMBLE System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive device for early detection of stent malfunctions in patients.
Funding Insights of NIMBLE Diagnostics
NIMBLE Diagnostics has successfully raised a total of $1.08M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $2.65 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $2.6M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Grant - NIMBLE Diagnostics | Valuation |
investors |
|
| Jun, 2023 | Amount | Grant - NIMBLE Diagnostics | Valuation |
investors |
|
| Jan, 2023 | Amount | Seed - NIMBLE Diagnostics | Valuation | Grow Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NIMBLE Diagnostics
NIMBLE Diagnostics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Ship2B, European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Grow Venture Partners is focused on investing in deep tech spin-offs.
|
Founded Year | Domain | Location | |
|
Namarel Ventures is focused on health sector startup investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NIMBLE Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NIMBLE Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nimble Diagnostics Comparisons
Competitors of NIMBLE Diagnostics
NIMBLE Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imperative Care, LUMA Vision, Verathon, Deltex Medical and eKuore, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Access catheters for neurovascular stroke treatment are provided.
|
|
| domain | founded_year | HQ Location |
Developer of interventional cardiac imaging devices
|
|
| domain | founded_year | HQ Location |
Medical devices for ultrasound imaging and airway management are developed.
|
|
| domain | founded_year | HQ Location |
A fluid management and cardiac output monitoring system
|
|
| domain | founded_year | HQ Location |
Wireless electronic stethoscopes are developed for cardiac anomaly detection.
|
|
| domain | founded_year | HQ Location |
Ultrathin pressure microcatheters for coronary stenosis diagnosis are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about NIMBLE Diagnostics
When was NIMBLE Diagnostics founded?
NIMBLE Diagnostics was founded in 2022.
Where is NIMBLE Diagnostics located?
NIMBLE Diagnostics is headquartered in Badalona, Spain. It is registered at Badalona, Cataluna, Spain.
Who is the current CEO of NIMBLE Diagnostics?
Oriol Iborra Egea is the current CEO of NIMBLE Diagnostics. They have also founded this company.
Is NIMBLE Diagnostics a funded company?
NIMBLE Diagnostics is a funded company, having raised a total of $1.08M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.08M, raised on Apr 19, 2022.
What does NIMBLE Diagnostics do?
NIMBLE Diagnostics was founded in 2022 in Badalona, Spain, within the medical diagnostics sector. A non-invasive device called the Nimble System is provided by the company to measure and quantify stent malfunctions in cardiovascular conditions. Patients are enabled to be monitored over time, regardless of the stents location, supporting ongoing assessment in clinical settings.
Who are the top competitors of NIMBLE Diagnostics?
NIMBLE Diagnostics's top competitors include Imperative Care, LUMA Vision and Verathon.
What products or services does NIMBLE Diagnostics offer?
NIMBLE Diagnostics offers NIMBLE System.
Who are NIMBLE Diagnostics's investors?
NIMBLE Diagnostics has 6 investors. Key investors include Ship2B, European Union, EIC Fund, Grow Venture Partners, and Inveniam Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.